Pharmacokinetics and pharmacodynamics of PF‐05231023, a novel long‐acting FGF21 mimetic, in a first‐in‐human study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|5|1051-1063

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.5, 2015-11, pp. : 1051-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

By Seino Yutaka   Nakajima Hiromu   Miyahara Hajime   Kurita Takashi   Bush Mark A.   Yang Fred   Stewart Murray W.    

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3049-3057

Informa Healthcare

Access to resources Recommend Favorite

UGT2B17 Genetic Polymorphisms Dramatically Affect the Pharmacokinetics of MK‐7246 in Healthy Subjects in a First‐in‐Human Study

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 96-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Everolimus in combination with octreotide long‐acting repeatable in a first‐line setting for patients with neuroendocrine tumors: An ITMO group study

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2457-2463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites

By  

Oncology, Vol. 82, Iss. 6, 2012-05 ,pp. : 315-320

Karger

Access to resources Recommend Favorite